Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study. - Fourati S; Reslan A; Bourret J; Casalegno JS; Rahou Y; Chollet L; Pillet S; Tremeaux P; Dossou NC; Gault E; Salmona M; Imbert-Marcille BM; et al. (The Lancet. Infectious diseases, 2025)